Developer docs
API playgroundTry for free, no card

Search company profiles

Aseptic Technologies

Full company profile

uuid0005uyw

Namestring
Aseptic Technologies
Legal namestring
Aseptic Technologies SA
Websiteurl
aseptictech.com
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Aseptic Technologies SA is a Belgian private company, founded in 2002 and headquartered in Gembloux (Crealys Science Park), that develops, manufactures, and markets aseptic fill & finish equipment and consumables for the pharmaceutical and biotech industries. Its core platform is the AT-Closed Vial® — a pre-assembled, radiation-sterilized polymer vial (Cyclic Olefin Copolymer body, Thermoplastic Elastomer stopper) that is sealed before filling and accessed through the stopper with a non-coring needle, mechanically reclosed, laser-re-sealed, then capped — paired with filling lines ranging from the semi-automated Crystal M1 (up to 200 vials/hour, installed in a biosafety cabinet) through the Crystal L1 (up to 500/hr in RABS), Cellana L1/XL1 (up to 700/hr isolated), to the commercial-scale Crystal PX (up to 4,500 vials/hour). Aseptic Technologies has been a member of SKAN Group since 2011 and in 2025 absorbed Plast4Life (its prior Simonis JV) to vertically integrate clean injection molding, with capacity scheduled to double by 2027; Aseptic Technologies also distributes through Sartorius Stedim Biotech (AT-Connector as Gammasart ATD™) and Yukon Medical (AT-Adapt). Customer-validated regulatory milestones include Drug Master Files on file with the US FDA for AT-Closed Vial® and AT-Cap™, ISO 9001:2015 and ISO 15378:2017 certifications, and approved drug products using the technology spanning FDA, EMA, MHRA, PMDA, Health Canada, and TGA — covering major commercial cell and gene therapies (Casgevy, Carvykti, Vyjuvek, Ryoncil, Ebvallo, Delytact, Beqvez, Durveqtix) and one veterinary biologic (ArtiCell Forte).

The company monetizes through four revenue streams: (i) capital equipment sales (Crystal M1/pure² M1/spectra M1/L1/XL1/PX filling lines and ancillary devices such as AT-Cellyx and AT-Etcher), with quote-based pricing tied to configuration and containment type; (ii) consumables and single-use systems (AT-Closed Vial®, AT-Cap, AT-Assembly, AT-Connect/AT-Connector, AT-Adapt, AT-Nest, AT-CryoBox, AT-Tray) delivered sterile (SAL 10⁻⁶), generating repeat purchases from each installed base; (iii) AT Academy training and LifeCycle Support services covering installation, IQ/OQ qualification, preventive maintenance, spare parts, retrofits, and remote/on-site support, delivered via SKAN's global LCS organization; and (iv) an irrevocable, non-exclusive, royalty-free worldwide license to fill and sell filled containers using AT-Closed Vial® technology within a defined field of use. Go-to-market is direct enterprise field sales with quote-based, multi-year contracts, complemented by channel partners (Sartorius Stedim, Yukon Medical) and thought-leadership content (webinars, case studies, industry events) targeting advanced therapy developers, CDMOs, hospital pharmacies, and next-generation biologics developers across Europe, North America, and Asia-Pacific.

Short descriptiontext

Aseptic Technologies SA, a Belgian private subsidiary of SKAN Group (founded 2002, Gembloux), designs and manufactures AT-Closed Vial® polymer vials and a portfolio of aseptic fill & finish equipment (Crystal M1 through Crystal PX) plus single-use systems for pharmaceutical, biotech, CDMO, hospital pharmacy, and advanced therapy customers worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersIsnes, Belgium
HQ citystring
Isnes
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aseptic fill finish, closed vial technology, pharmaceutical filling equipment, cell gene therapy manufacturing, clean injection molding
Industry5 codes
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMALAOAB
Filling & Dosing Equipment (Liquid, Powder, Aseptic)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)
NAICS code2 codes
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Gaskets, Packg & Sealg Devices & Rubber & Plastics Hose3050
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Pharmaceutical Aseptic Fill & Finish Equipment
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Aseptic Filling Equipment Sales
TypeHardware Sales
Description

Sale of aseptic filling machines including Crystal M1, pure² M1, spectra M1, Crystal L1, Cellana L1, Cellana XL1, and Crystal PX filling lines. Equipment is sold directly to pharmaceutical and biotech companies, CDMOs, hospital pharmacies, and academic institutions. Pricing is quote-based with lead times varying by product (e.g., Crystal M1 delivered in 6 weeks; L1 in RABS installed and qualified in 1 week).

aseptictech.com
2Consumables and Single-Use Systems
TypeTransaction Fee
Description

Recurring revenue from consumables including AT-Closed Vial® (in AT-CryoBox, AT-Nest, AT-Tray formats), AT-Cap, AT-Assembly (single-use fluid path), AT-Connect, AT-Connector, AT-Adapt, AT-Nest, AT-CryoBox packaging. Consumables are delivered sterile (SAL 10⁻⁶) and are repeat-purchase items for customers running filling operations.

aseptictech.com
3LifeCycle Support (LCS) Services
TypeProfessional Services
Description

Comprehensive service contracts and standalone services covering installation, IQ/OQ qualification, preventive maintenance, operator and advanced technical training (AT Academy), troubleshooting (remote and on-site), spare parts supply, and retrofit/upgrade services. LCS team is based across SKAN locations worldwide.

aseptictech.com
4AT-Closed Vial® and AT-Cap Licensing
TypeLicensing Royalties
Description

AT-Closed Vial® Technology is subject to industrial property rights. At the date of transfer of property, AT provides the product user and its successors an irrevocable, non-exclusive worldwide royalty-free license to fill containers and sell filled containers using the AT-Closed Vial® Technology within the defined Field of use (vaccines, cell therapy, and injectable substances for human/veterinary applications).

aseptictech.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Enterprise Equipment — Custom Quoted
ModelOtherBilling cadenceMulti-year contract
Notes

Equipment sold directly to pharma/biotech companies, CDMOs, hospitals. Quotes are request-based, tailored to equipment configuration (Crystal M1, pure² M1, spectra M1, L1, XL1, PX lines), containment type (BSC, RABS, isolator), automation level, and geographic delivery terms (Incoterms 2020 DDP).

aseptictech.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 12 records shown
1AT-Closed Vial®
Description

Ready-to-fill polymer vials (COC) with TPE stoppers that are closed before filling, designed for aseptic fill & finish and cryogenic storage of cell and gene therapy products.

aseptictech.com
+11 more records
Core offering1 text field

Aseptic Technologies designs, manufactures, and sells aseptic fill & finish solutions for the pharmaceutical industry, centered on the proprietary AT-Closed Vial® polymer vial system. The product portfolio spans semi-automated tabletop filling stations (Crystal M1), isolated filling units (pure² M1, spectra M1), robotic lines in RABS/isolators (Crystal L1, Cellana L1, Cellana XL1), and high-speed commercial filling lines (Crystal PX up to 4,500 vials/hour), along with single-use devices, aseptic transfer systems, ancillary equipment, and LifeCycle Support services.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 500+ equipment units in operation globally
+6 more records
Product overview1 text field

Aseptic Technologies offers a comprehensive aseptic fill & finish portfolio centered on the AT-Closed Vial technology - a polymer vial system where vials are closed before filling, eliminating contamination risks. The product line spans from manual tabletop systems (Crystal M1) to fully automated high-speed lines (Crystal PX), and includes single-use devices (AT-Assembly, AT-Adapt, AT-Port System) and ancillary equipment (AT-Cellyx, AT-Etcher). Services include clean injection molding, single-use system manufacturing, and LifeCycle Support. The company operates as a member of SKAN Group, combining AT-Closed Vial technology with SKAN isolators for integrated solutions.

Product and service7 records
1AT-Closed Vial®
CategoryPrimary Packaging / Vial
Description

Ready-to-fill polymer vials (COC body, TPE stopper) closed before filling, molded and assembled in ISO 5 conditions; available in volumes from 1 mL to 50 mL with validated Container Closure Integrity during cryopreservation down to liquid nitrogen temperatures. Used by pharmaceutical and biotech companies for aseptic fill & finish of cell therapies, gene therapies, vaccines, and injectable biologics.

2Crystal M1 Filling Station
CategoryFilling Equipment
Description

Tabletop semi-automated aseptic filling system for small batches, processing up to 200 AT-Closed Vials per hour with filling volumes from 0.1 mL to 50 mL. Designed for installation in a biosafety cabinet or isolator, installed and qualified in 1 day. For cGMP small-batch manufacturing, process development, and R&D.

3pure² M1
CategoryFilling Equipment
Description

Plug-and-play isolated fill & finish unit combining AT-Closed Vial® technology with SKAN pure² isolator shell. Dedicated to small cGMP batches; no HVAC connection required; fast H2O2 decontamination.

4spectra M1
CategoryFilling Equipment
Description

Isolated fill & finish unit combining AT-Closed Vial® technology with SKAN spectra isolator, featuring integrated nanox catalyst and skanfog decontamination for optimized cycles in small cGMP batches.

5Crystal L1 Robot Line in RABS
CategoryFilling Equipment
Description

Semi-automated robotic aseptic filling line with active Restricted-Access Barrier System (RABS), processing up to 500 AT-Closed Vials per hour; installed in Grade B environment with minimal footprint. Installed and qualified in 1 week.

6Cellana L1 Robot Line
CategoryFilling Equipment
Description

Automated isolated fill & finish line processing up to 500 vials per hour with 100% weight in-process control; integrated H2O2 decontamination system enables installation in lower-class cleanroom environments.

7Cellana XL1 Robot Line
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Aseptic Technologies has been a member of SKAN Group since 2011. SKAN is a Swiss global market leader for isolators, cleanroom devices, and decontamination processes for aseptic biopharmaceutical production. The partnership combines Aseptic Technologies' AT-Closed Vial® filling technology with SKAN's isolator design (pure², spectra, Cellana). Together they provide integrated fill & finish solutions for ATMP products, from cell processing to plug-and-play isolated filling. SKAN LifeCycle Support experts provide worldwide service coverage for Aseptic Technologies equipment.

Strategic tierKeyTypeChannel Partner/ Reseller/ Distributor
Description

Sartorius Stedim Biotech distributes the AT-Connector (large-volume aseptic liquid transfer device for use with AT-Port System) under the brand name Gammasart Aseptic Transfer Device (ATD™). This partnership extends Aseptic Technologies' market reach into Sartorius Stedim's extensive bioprocessing customer base worldwide.

Strategic tierKeyTypeChannel Partner/ Reseller/ Distributor
Description

Yukon Medical is the exclusive worldwide distributor of the AT-Adapt, a dedicated stand-alone disposable device for needle-free vial access designed for use with AT-Closed Vial® by healthcare professionals in hospitals and pharmacies.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Italian-headquartered manufacturer of aseptic processing and filling equipment for the pharmaceutical industry, including vial filling, lyophilization, and isolation technology. Overlaps directly with Aseptic Technologies' aseptic fill-finish equipment portfolio.

TypeBroad incumbent
Description

European-based manufacturer of pharmaceutical glass and plastic primary packaging (vials, syringes, bottles, containers) plus devices and solutions for injectables. Competes broadly in primary packaging formats for sterile injectable drugs, overlapping with AT-Closed Vial's positioning.

TypeDirect peer
Description

Italian manufacturer of pharmaceutical glass containers (vials, syringes, cartridges) and integrated fill-finish equipment, including the EZ-fill® ready-to-use platform. Direct competitor offering both primary packaging and aseptic filling solutions overlapping with AT-Closed Vial and the Crystal/PX lines.

TypeOthers
Description

Global bioprocessing supplier offering cell culture, filtration, single-use, and process development technologies for biologics and cell/gene therapy manufacturing. Adjacent peer serving overlapping customer base (CDMOs, ATMP developers) rather than competing directly in fill-finish equipment or vials.

TypeBroad incumbent
Description

Global medical technology company whose BD Medical segment supplies prefillable syringe systems, vials, and drug delivery devices for injectable pharmaceuticals. A broad incumbent in primary container and delivery systems competing for ATMP fill-finish specifications.

TypeBroad incumbent
Description

Global leader in elastomeric closures, seals, and primary packaging components for injectable drug delivery, with growing portfolio of polymer-based container systems and integrated delivery platforms. Adjacent competitor in primary container components used in aseptic fill-finish.

TypeBroad incumbent
Description

Leading manufacturer of pharmaceutical glass vials, ampoules, syringes, and cartridges serving the global injectables market. Competes as the incumbent primary packaging format versus AT-Closed Vial's polymer alternative, and is investing in polymer/specialty containers for biologics.

TypeOthers
Description

Global bioprocessing supplier of single-use technologies, fluid management, and aseptic transfer solutions, and existing channel partner for AT-Connector (distributed as Gammasart ATD™). Comparable in single-use fluid-path and aseptic transfer categories rather than direct filling equipment.

TypeDirect peer
Description

Global supplier of processing and packaging equipment for the pharmaceutical industry, including aseptic fill-finish systems for vials, ampoules, and prefilled syringes. Direct peer in aseptic filling equipment serving pharma, biotech, and CDMO customers.

TypeDirect peer
Description

German manufacturer of aseptic filling and closing machines for vials, syringes, and cartridges used in pharmaceutical manufacturing. Direct competitor to Aseptic Technologies' Crystal M1, L1, XL1, and PX filling lines in sterile fill-finish equipment for injectables.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aseptic Technologies

Pharmaceutical Aseptic Fill & Finish Equipmentaseptictech.com

Aseptic Technologies SA, a Belgian private subsidiary of SKAN Group (founded 2002, Gembloux), designs and manufactures AT-Closed Vial® polymer vials and a portfolio of aseptic fill & finish equipment (Crystal M1 through Crystal PX) plus single-use systems for pharmaceutical, biotech, CDMO, hospital pharmacy, and advanced therapy customers worldwide.

What Aseptic Technologies does

Aseptic Technologies SA is a Belgian private company, founded in 2002 and headquartered in Gembloux (Crealys Science Park), that develops, manufactures, and markets aseptic fill & finish equipment and consumables for the pharmaceutical and biotech industries. Its core platform is the AT-Closed Vial® — a pre-assembled, radiation-sterilized polymer vial (Cyclic Olefin Copolymer body, Thermoplastic Elastomer stopper) that is sealed before filling and accessed through the stopper with a non-coring needle, mechanically reclosed, laser-re-sealed, then capped — paired with filling lines ranging from the semi-automated Crystal M1 (up to 200 vials/hour, installed in a biosafety cabinet) through the Crystal L1 (up to 500/hr in RABS), Cellana L1/XL1 (up to 700/hr isolated), to the commercial-scale Crystal PX (up to 4,500 vials/hour). Aseptic Technologies has been a member of SKAN Group since 2011 and in 2025 absorbed Plast4Life (its prior Simonis JV) to vertically integrate clean injection molding, with capacity scheduled to double by 2027; Aseptic Technologies also distributes through Sartorius Stedim Biotech (AT-Connector as Gammasart ATD™) and Yukon Medical (AT-Adapt). Customer-validated regulatory milestones include Drug Master Files on file with the US FDA for AT-Closed Vial® and AT-Cap™, ISO 9001:2015 and ISO 15378:2017 certifications, and approved drug products using the technology spanning FDA, EMA, MHRA, PMDA, Health Canada, and TGA — covering major commercial cell and gene therapies (Casgevy, Carvykti, Vyjuvek, Ryoncil, Ebvallo, Delytact, Beqvez, Durveqtix) and one veterinary biologic (ArtiCell Forte).

The company monetizes through four revenue streams: (i) capital equipment sales (Crystal M1/pure² M1/spectra M1/L1/XL1/PX filling lines and ancillary devices such as AT-Cellyx and AT-Etcher), with quote-based pricing tied to configuration and containment type; (ii) consumables and single-use systems (AT-Closed Vial®, AT-Cap, AT-Assembly, AT-Connect/AT-Connector, AT-Adapt, AT-Nest, AT-CryoBox, AT-Tray) delivered sterile (SAL 10⁻⁶), generating repeat purchases from each installed base; (iii) AT Academy training and LifeCycle Support services covering installation, IQ/OQ qualification, preventive maintenance, spare parts, retrofits, and remote/on-site support, delivered via SKAN's global LCS organization; and (iv) an irrevocable, non-exclusive, royalty-free worldwide license to fill and sell filled containers using AT-Closed Vial® technology within a defined field of use. Go-to-market is direct enterprise field sales with quote-based, multi-year contracts, complemented by channel partners (Sartorius Stedim, Yukon Medical) and thought-leadership content (webinars, case studies, industry events) targeting advanced therapy developers, CDMOs, hospital pharmacies, and next-generation biologics developers across Europe, North America, and Asia-Pacific.

Aseptic Technologies firmographics

Firmographics
Name
Aseptic Technologies
Legal name
Aseptic Technologies SA
Website
https://aseptictech.com
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Aseptic Technologies SA, a Belgian private subsidiary of SKAN Group (founded 2002, Gembloux), designs and manufactures AT-Closed Vial® polymer vials and a portfolio of aseptic fill & finish equipment (Crystal M1 through Crystal PX) plus single-use systems for pharmaceutical, biotech, CDMO, hospital pharmacy, and advanced therapy customers worldwide.
Ownership category
akta.pro rank

Aseptic Technologies industry classification

Industry
Product category
Pharmaceutical Aseptic Fill & Finish Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Gaskets, Packg & Sealg Devices & Rubber & Plastics Hose (3050), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAAAJAG
Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces)
Healthcare & Life Sciences/Biotechnology & Biologics/Bioprocessing & Biomanufacturing Technology (upstream/downstream, single-use, analytics)
SECONDARYIMALAOAB
Filling & Dosing Equipment (Liquid, Powder, Aseptic)
SECONDARYHLAGABAH
Sterile Fill-Finish & Aseptic Manufacturing CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGAGAG
Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Biopharma Manufacturing Services (Biologics/Cell & Gene)
SECONDARYIMALAIAB
Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers)

Keywords

  • Aseptic fill finish
  • Closed vial technology
  • Pharmaceutical filling equipment
  • Cell gene therapy manufacturing
  • Clean injection molding

Where Aseptic Technologies is headquartered

Location

Headquarters

HQ city
Isnes
HQ country
Belgium
HQ region
Europe

Offices4 records

Markets served

Aseptic Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Aseptic Filling Equipment Sales: Sale of aseptic filling machines including Crystal M1, pure² M1, spectra M1, Crystal L1, Cellana L1, Cellana XL1, and Crystal PX filling lines. Equipment is sold directly to pharmaceutical and biotech companies, CDMOs, hospital pharmacies, and academic institutions. Pricing is quote-based with lead times varying by product (e.g., Crystal M1 delivered in 6 weeks; L1 in RABS installed and qualified in 1 week).
  2. Consumables and Single-Use Systems: Recurring revenue from consumables including AT-Closed Vial® (in AT-CryoBox, AT-Nest, AT-Tray formats), AT-Cap, AT-Assembly (single-use fluid path), AT-Connect, AT-Connector, AT-Adapt, AT-Nest, AT-CryoBox packaging. Consumables are delivered sterile (SAL 10⁻⁶) and are repeat-purchase items for customers running filling operations.
  3. LifeCycle Support (LCS) Services: Comprehensive service contracts and standalone services covering installation, IQ/OQ qualification, preventive maintenance, operator and advanced technical training (AT Academy), troubleshooting (remote and on-site), spare parts supply, and retrofit/upgrade services. LCS team is based across SKAN locations worldwide.
  4. AT-Closed Vial® and AT-Cap Licensing: AT-Closed Vial® Technology is subject to industrial property rights. At the date of transfer of property, AT provides the product user and its successors an irrevocable, non-exclusive worldwide royalty-free license to fill containers and sell filled containers using the AT-Closed Vial® Technology within the defined Field of use (vaccines, cell therapy, and injectable substances for human/veterinary applications).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise Equipment — Custom Quoted

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Aseptic Technologies product offering

Product offering

Core offering

Aseptic Technologies designs, manufactures, and sells aseptic fill & finish solutions for the pharmaceutical industry, centered on the proprietary AT-Closed Vial® polymer vial system. The product portfolio spans semi-automated tabletop filling stations (Crystal M1), isolated filling units (pure² M1, spectra M1), robotic lines in RABS/isolators (Crystal L1, Cellana L1, Cellana XL1), and high-speed commercial filling lines (Crystal PX up to 4,500 vials/hour), along with single-use devices, aseptic transfer systems, ancillary equipment, and LifeCycle Support services.

Product overview

Aseptic Technologies offers a comprehensive aseptic fill & finish portfolio centered on the AT-Closed Vial technology - a polymer vial system where vials are closed before filling, eliminating contamination risks. The product line spans from manual tabletop systems (Crystal M1) to fully automated high-speed lines (Crystal PX), and includes single-use devices (AT-Assembly, AT-Adapt, AT-Port System) and ancillary equipment (AT-Cellyx, AT-Etcher). Services include clean injection molding, single-use system manufacturing, and LifeCycle Support. The company operates as a member of SKAN Group, combining AT-Closed Vial technology with SKAN isolators for integrated solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • AT-Closed Vial®: Ready-to-fill polymer vials (COC) with TPE stoppers that are closed before filling, designed for aseptic fill & finish and cryogenic storage of cell and gene therapy products.
  • Crystal M1
  • pure² M1
  • spectra M1
  • Crystal L1 Robot Line
  • Cellana L1 Robot Line
  • Cellana XL1
  • Crystal PX
  • AT-Port System
  • AT-Assembly
  • AT-Cellyx
  • AT-Etcher

Products and services

  • AT-Closed Vial® Ready-to-fill polymer vials (COC body, TPE stopper) closed before filling, molded and assembled in ISO 5 conditions; available in volumes from 1 mL to 50 mL with validated Container Closure Integrity during cryopreservation down to liquid nitrogen temperatures. Used by pharmaceutical and biotech companies for aseptic fill & finish of cell therapies, gene therapies, vaccines, and injectable biologics.
  • Crystal M1 Filling Station Tabletop semi-automated aseptic filling system for small batches, processing up to 200 AT-Closed Vials per hour with filling volumes from 0.1 mL to 50 mL. Designed for installation in a biosafety cabinet or isolator, installed and qualified in 1 day. For cGMP small-batch manufacturing, process development, and R&D.
  • pure² M1 Plug-and-play isolated fill & finish unit combining AT-Closed Vial® technology with SKAN pure² isolator shell. Dedicated to small cGMP batches; no HVAC connection required; fast H2O2 decontamination.
  • spectra M1 Isolated fill & finish unit combining AT-Closed Vial® technology with SKAN spectra isolator, featuring integrated nanox catalyst and skanfog decontamination for optimized cycles in small cGMP batches.
  • Crystal L1 Robot Line in RABS Semi-automated robotic aseptic filling line with active Restricted-Access Barrier System (RABS), processing up to 500 AT-Closed Vials per hour; installed in Grade B environment with minimal footprint. Installed and qualified in 1 week.
  • Cellana L1 Robot Line Automated isolated fill & finish line processing up to 500 vials per hour with 100% weight in-process control; integrated H2O2 decontamination system enables installation in lower-class cleanroom environments.
  • Cellana XL1 Robot Line

Quantifiable outcome

  • 500+ equipment units in operation globally
  • +6 more outcomes

Companies that use Aseptic Technologies

Customer profile

Named customers13 records

Segments5 records

Ideal customer profiles4 records

Aseptic Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature10 records

Aseptic Technologies partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and key.

  • SKAN GroupcoreStrategic or Co-development PartnerAseptic Technologies has been a member of SKAN Group since 2011. SKAN is a Swiss global market leader for isolators, cleanroom devices, and decontamination processes for aseptic biopharmaceutical production. The partnership combines Aseptic Technologies' AT-Closed Vial® filling technology with SKAN's isolator design (pure², spectra, Cellana). Together they provide integrated fill & finish solutions for ATMP products, from cell processing to plug-and-play isolated filling. SKAN LifeCycle Support experts provide worldwide service coverage for Aseptic Technologies equipment.
  • Sartorius Stedim BiotechkeyChannel Partner/ Reseller/ DistributorSartorius Stedim Biotech distributes the AT-Connector (large-volume aseptic liquid transfer device for use with AT-Port System) under the brand name Gammasart Aseptic Transfer Device (ATD™). This partnership extends Aseptic Technologies' market reach into Sartorius Stedim's extensive bioprocessing customer base worldwide.
  • Yukon MedicalkeyChannel Partner/ Reseller/ DistributorYukon Medical is the exclusive worldwide distributor of the AT-Adapt, a dedicated stand-alone disposable device for needle-free vial access designed for use with AT-Closed Vial® by healthcare professionals in hospitals and pharmacies.

Scale indicators5 records

Recent moves5 records

Expansion highlights6 records

Aseptic Technologies competitors and assessment

Company assessment

Direct peers

  • IMA Life (IMA S.p.A.): Italian-headquartered manufacturer of aseptic processing and filling equipment for the pharmaceutical industry, including vial filling, lyophilization, and isolation technology. Overlaps directly with Aseptic Technologies' aseptic fill-finish equipment portfolio.
  • Stevanato Group: Italian manufacturer of pharmaceutical glass containers (vials, syringes, cartridges) and integrated fill-finish equipment, including the EZ-fill® ready-to-use platform. Direct competitor offering both primary packaging and aseptic filling solutions overlapping with AT-Closed Vial and the Crystal/PX lines.
  • Syntegon Technology (formerly Bosch Packaging Technology): Global supplier of processing and packaging equipment for the pharmaceutical industry, including aseptic fill-finish systems for vials, ampoules, and prefilled syringes. Direct peer in aseptic filling equipment serving pharma, biotech, and CDMO customers.
  • Bausch + Strobel Machine Company: German manufacturer of aseptic filling and closing machines for vials, syringes, and cartridges used in pharmaceutical manufacturing. Direct competitor to Aseptic Technologies' Crystal M1, L1, XL1, and PX filling lines in sterile fill-finish equipment for injectables.

Broad incumbents

  • Gerresheimer AG: European-based manufacturer of pharmaceutical glass and plastic primary packaging (vials, syringes, bottles, containers) plus devices and solutions for injectables. Competes broadly in primary packaging formats for sterile injectable drugs, overlapping with AT-Closed Vial's positioning.
  • Becton, Dickinson and Company (BD): Global medical technology company whose BD Medical segment supplies prefillable syringe systems, vials, and drug delivery devices for injectable pharmaceuticals. A broad incumbent in primary container and delivery systems competing for ATMP fill-finish specifications.
  • West Pharmaceutical Services: Global leader in elastomeric closures, seals, and primary packaging components for injectable drug delivery, with growing portfolio of polymer-based container systems and integrated delivery platforms. Adjacent competitor in primary container components used in aseptic fill-finish.
  • Schott AG (SCHOTT Pharma): Leading manufacturer of pharmaceutical glass vials, ampoules, syringes, and cartridges serving the global injectables market. Competes as the incumbent primary packaging format versus AT-Closed Vial's polymer alternative, and is investing in polymer/specialty containers for biologics.

Others

  • Cytiva (Danaher): Global bioprocessing supplier offering cell culture, filtration, single-use, and process development technologies for biologics and cell/gene therapy manufacturing. Adjacent peer serving overlapping customer base (CDMOs, ATMP developers) rather than competing directly in fill-finish equipment or vials.
  • Sartorius Stedim Biotech: Global bioprocessing supplier of single-use technologies, fluid management, and aseptic transfer solutions, and existing channel partner for AT-Connector (distributed as Gammasart ATD™). Comparable in single-use fluid-path and aseptic transfer categories rather than direct filling equipment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Aseptic Technologies social profiles

Digital presence

Aseptic Technologies compliance and trust

Trust signal

Compliance3 records

Aseptic Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aseptic Technologies leadership team

Management profile

Number of profiles

Profiles3 records

Aseptic Technologies subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Aseptic Technologies funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aseptic Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aseptic Technologies

What does Aseptic Technologies do?

Aseptic Technologies designs, manufactures, and sells aseptic fill & finish solutions for the pharmaceutical industry, centered on the proprietary AT-Closed Vial® polymer vial system. The product portfolio spans semi-automated tabletop filling stations (Crystal M1), isolated filling units (pure² M1, spectra M1), robotic lines in RABS/isolators (Crystal L1, Cellana L1, Cellana XL1), and high-speed commercial filling lines (Crystal PX up to 4,500 vials/hour), along with single-use devices, aseptic transfer systems, ancillary equipment, and LifeCycle Support services.

Is Aseptic Technologies a public or private company?

Aseptic Technologies is a private company. It is classified as corporate owned and is currently operating.

When was Aseptic Technologies founded?

Aseptic Technologies was founded in 2002. It employs 51 to 100 people.

Where is Aseptic Technologies based?

Aseptic Technologies is headquartered in Isnes, Belgium, in the Europe region.

How does Aseptic Technologies make money?

Four revenue lines are on record. Aseptic Filling Equipment Sales are the primary driver. The others are consumables and Single-Use Systems, lifeCycle Support (LCS) Services and AT-Closed Vial® and AT-Cap Licensing.

Who are Aseptic Technologies's main competitors?

Direct peers on record are IMA Life (IMA S.p.A.), Stevanato Group, Syntegon Technology (formerly Bosch Packaging Technology) and Bausch + Strobel Machine Company. Broad incumbents are Gerresheimer AG, Becton, Dickinson and Company (BD), West Pharmaceutical Services and Schott AG (SCHOTT Pharma). Others are Cytiva (Danaher) and Sartorius Stedim Biotech.

Does Aseptic Technologies have an API?

No public API is recorded for Aseptic Technologies.

What industry is Aseptic Technologies in?

Aseptic Technologies's product category is Pharmaceutical Aseptic Fill & Finish Equipment. Its primary akta.pro industry code is HLAAAJAG, Aseptic Processing, Fill-Finish & Sterile Manufacturing Tech (isolators, lyophilization interfaces), with a secondary code of IMALAOAB, Filling & Dosing Equipment (Liquid, Powder, Aseptic). Its NAICS code is 3345 and its SIC code is 3050.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales